Zoetis Inc. (ZTS) Shares Bought by HL Financial Services LLC
HL Financial Services LLC lifted its position in shares of Zoetis Inc. (NYSE:ZTS) by 16.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,758 shares of the company’s stock after acquiring an additional 8,927 shares during the quarter. HL Financial Services LLC’s holdings in Zoetis were worth $4,065,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd boosted its stake in shares of Zoetis by 7.3% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 5,901 shares of the company’s stock worth $368,000 after acquiring an additional 401 shares in the last quarter. Wells Fargo & Company MN lifted its stake in Zoetis by 8.2% in the 2nd quarter. Wells Fargo & Company MN now owns 5,113,948 shares of the company’s stock valued at $319,008,000 after buying an additional 389,260 shares in the last quarter. Swiss National Bank lifted its stake in Zoetis by 8.1% in the 2nd quarter. Swiss National Bank now owns 1,796,380 shares of the company’s stock valued at $112,058,000 after buying an additional 133,900 shares in the last quarter. Balyasny Asset Management LLC lifted its stake in Zoetis by 55.5% in the 2nd quarter. Balyasny Asset Management LLC now owns 44,330 shares of the company’s stock valued at $2,765,000 after buying an additional 15,830 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in Zoetis by 13.9% in the 2nd quarter. Victory Capital Management Inc. now owns 277,641 shares of the company’s stock valued at $17,320,000 after buying an additional 33,894 shares in the last quarter. 92.90% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.watchlistnews.com/zoetis-inc-zts-shares-bought-by-hl-financial-services-llc/1696115.html.
Several brokerages have weighed in on ZTS. BMO Capital Markets reiterated a “hold” rating and issued a $65.00 price target on shares of Zoetis in a report on Thursday, November 2nd. Cantor Fitzgerald set a $75.00 price target on Zoetis and gave the company a “buy” rating in a report on Monday, August 14th. Stifel Nicolaus reiterated a “buy” rating and issued a $65.00 price target on shares of Zoetis in a report on Friday, September 1st. Deutsche Bank AG reiterated a “buy” rating and issued a $65.00 price target (up from $62.00) on shares of Zoetis in a report on Monday, July 17th. Finally, BidaskClub downgraded Zoetis from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 20th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $67.06.
Zoetis Inc. (NYSE:ZTS) traded down $0.17 on Friday, reaching $69.13. 1,905,700 shares of the company traded hands, compared to its average volume of 2,817,385. The firm has a market capitalization of $33,769.08, a price-to-earnings ratio of 31.79, a price-to-earnings-growth ratio of 2.03 and a beta of 1.02. Zoetis Inc. has a 52-week low of $48.24 and a 52-week high of $70.48. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45.
Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. Zoetis’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.52 earnings per share. equities analysts anticipate that Zoetis Inc. will post 2.36 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be paid a dividend of $0.105 per share. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 annualized dividend and a yield of 0.61%. Zoetis’s dividend payout ratio (DPR) is 22.11%.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.